UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel organic semiconductors based on 2-amino-anthracene: Synthesis, charge transport and photo-conductive properties

Physical chemistry chemical physics : PCCP, 2021-07, Vol.23 (25), p.13885-13894

2021

Volltextzugriff (PDF)

Cyclodextrin modified PLLA parietal reinforcement implant with prolonged antibacterial activity

Acta biomaterialia, 2017-04, Vol.53, p.222-232

2017

Volltextzugriff (PDF)

Immobilization of fluorescent chemosensor on pyrogenic silica: A promising device for gaseous detection

Journal of colloid and interface science, 2015-07, Vol.450, p.62-67

2015

Volltextzugriff (PDF)

Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type

Neuroscience and biobehavioral reviews, 2019-02, Vol.97, p.70-84

2019

Volltextzugriff (PDF)

A multiple ascending dose study with evidence for target engagement of BNC210; a negative allosteric modulator of alpha7 nAChR in development for anxiety

European neuropsychopharmacology, 2016-10, Vol.26, p.S609-S609

2016

Volltextzugriff (PDF)

A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

British journal of clinical pharmacology, 1999-09, Vol.48 (3), p.367-374

1999

Volltextzugriff (PDF)

P.1.c.039 Oculomotricity does not influence resting gamma EEG activity following a sub-anaesthetic dose of ketamine

European neuropsychopharmacology, 2011, Vol.21, p.S275-S275

2011

Volltextzugriff (PDF)

Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance

Human psychopharmacology, 1998-11, Vol.13 (S2), p.S98-S107

1998

Volltextzugriff (PDF)

Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens

Journal of clinical psychopharmacology, 1998-06, Vol.18 (3), p.212-221

1998

Volltextzugriff (PDF)

Safety and tolerance profile of venlafaxine

International clinical psychopharmacology, 1995-03, Vol.10 Suppl 2, p.15-20

1995

Volltextzugriff (PDF)

Ethical Design Intelligence: The Virtuous Designer

d’Anjou, Philippe

1st edition., 2020

Volltextzugriff (PDF)

Renal angiomyolipoma: growth followed up with CT and/or US

Radiology, 1995-12, Vol.197 (3), p.598-602

1995

Volltextzugriff (PDF)

P.4.b.016 - A multiple ascending dose study with evidence for target engagement of BNC210; a negative allosteric modulator of alpha7 nAChR in development for anxiety

European neuropsychopharmacology, 2016-10, Vol.26, p.S609-S609

2016

Volltextzugriff (PDF)

Laparoscopically‐assisted percutaneous nephrolithotomy for the treatment of anterior calyceal diverticula

BJU international, 2000-12, Vol.86 (9), p.1088-1089

2000

Volltextzugriff (PDF)

Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers

European neuropsychopharmacology, 2001-08, Vol.11 (4), p.301-305

2001

Volltextzugriff (PDF)

Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance

Journal of clinical psychopharmacology, 2002-12, Vol.22 (6), p.576-583

2002

Volltextzugriff (PDF)

The art of design

Ethical Design Intelligence, 2020, p.79-101

d’Anjou, Philippe

1, 2020

Volltextzugriff (PDF)

Virtue design beyond designers

Ethical Design Intelligence, 2020, p.103-116

d’Anjou, Philippe

1, 2020

Volltextzugriff (PDF)

On freedom in design

Ethical Design Intelligence, 2020, p.47-77

d’Anjou, Philippe

1, 2020

Volltextzugriff (PDF)

Intangible ethicality

Ethical Design Intelligence, 2020, p.117-137

d’Anjou, Philippe

1, 2020

Volltextzugriff (PDF)

Design and unsustainability

Ethical Design Intelligence, 2020, p.139-151

d’Anjou, Philippe

1, 2020

Volltextzugriff (PDF)

Virtue design

Ethical Design Intelligence, 2020, p.7-46

d’Anjou, Philippe

1, 2020

Volltextzugriff (PDF)

Assessment of erectogenic properties of apomorphine and yohimbine in man

British journal of clinical pharmacology, 1988-12, Vol.26 (6), p.733-739

1988

Volltextzugriff (PDF)

Sensitivity and specificity to amphetamine of a french version of the 49-item form of the addiction research center inventory

Drug and alcohol dependence, 1997-05, Vol.45 (3), p.177-183

1997

Volltextzugriff (PDF)

Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist

International clinical psychopharmacology, 1994-09, Vol.9 (3), p.155-162

1994

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(59)
Science & Technology
(51)
Life Sciences & Biomedicine
(47)
Male
(44)
Adult
(37)
Biological And Medical Sciences
(33)
Medical Sciences
(32)
Female
(28)
Pharmacology & Pharmacy
(25)
Pharmacology. Drug Treatments
(24)
Double-Blind Method
(20)
Psychiatry
(16)
Middle Aged
(15)
Life Sciences
(13)
Psychomotor Performance - Drug Effects
(11)
Psychopharmacology
(11)
Neuropharmacology
(10)
Psychology. Psychoanalysis. Psychiatry
(10)
Memory - Drug Effects
(9)
Social Sciences
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel organic semiconductors based on 2-amino-anthracene: Synthesis, charge transport and photo-conductive properties

Cyclodextrin modified PLLA parietal reinforcement implant with prolonged antibacterial activity

Immobilization of fluorescent chemosensor on pyrogenic silica: A promising device for gaseous detection

Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type

A multiple ascending dose study with evidence for target engagement of BNC210; a negative allosteric modulator of alpha7 nAChR in development for anxiety

A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

P.1.c.039 Oculomotricity does not influence resting gamma EEG activity following a sub-anaesthetic dose of ketamine

Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance

Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens

Safety and tolerance profile of venlafaxine

Ethical Design Intelligence: The Virtuous Designer

Renal angiomyolipoma: growth followed up with CT and/or US

P.4.b.016 - A multiple ascending dose study with evidence for target engagement of BNC210; a negative allosteric modulator of alpha7 nAChR in development for anxiety

Laparoscopically‐assisted percutaneous nephrolithotomy for the treatment of anterior calyceal diverticula

Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers

Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance

The art of design

Virtue design beyond designers

On freedom in design

Intangible ethicality

Design and unsustainability

Virtue design

Assessment of erectogenic properties of apomorphine and yohimbine in man

Sensitivity and specificity to amphetamine of a french version of the 49-item form of the addiction research center inventory

Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist

Suchergebnisse filtern